Department of Microbiology, Metropolitana Sud Territorial Clinical Laboratory, Bellvitge University Hospital, Institut Català de la Salut (ICS), 08907 Hospitalet de Llobregat, Spain.
Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Spain.
Int J Mol Sci. 2024 May 17;25(10):5481. doi: 10.3390/ijms25105481.
Our aim was to develop an accurate, highly sensitive method for HBV genotype determination and detection of genotype mixtures. We examined the preS and 5' end of the HBV X gene (5X) regions of the HBV genome using next-generation sequencing (NGS). The 1852 haplotypes obtained were subjected to genotyping via the Distance-Based discrimination method (DB Rule) using two sets of 95 reference sequences of genotypes A-H. In clinical samples from 125 patients, the main genotypes were A, D, F and H in Caucasian, B and C in Asian and A and E in Sub-Saharan patients. Genotype mixtures were identified in 28 (22.40%) cases, and potential intergenotypic recombination was observed in 29 (23.20%) cases. Furthermore, we evaluated sequence conservation among haplotypes classified into genotypes A, C, D, and E by computing the information content. The preS haplotypes exhibited limited shared conserved regions, whereas the 5X haplotypes revealed two groups of conserved regions across the genotypes assessed. In conclusion, we developed an NGS-based HBV genotyping method utilizing the DB Rule for genotype classification. We identified two regions conserved across different genotypes at 5X, offering promising targets for RNA interference-based antiviral therapies.
我们的目的是开发一种准确、高度敏感的乙型肝炎病毒(HBV)基因型测定和混合基因型检测方法。我们使用下一代测序(NGS)技术检测了 HBV 基因组的前 S 和 5'末端 X 基因(5X)区域。通过使用两套 95 个基因型 A-H 的参考序列,采用基于距离的区分方法(DB Rule)对获得的 1852 个单倍型进行了基因分型。在 125 名患者的临床样本中,主要基因型为高加索人群的 A、D、F 和 H,亚洲人群的 B 和 C,以及撒哈拉以南非洲人群的 A 和 E。在 28 例(22.40%)病例中发现了基因型混合,在 29 例(23.20%)病例中观察到潜在的基因型间重组。此外,我们通过计算信息含量来评估分类为基因型 A、C、D 和 E 的单倍型之间的序列保守性。前 S 单倍型表现出有限的共享保守区域,而 5X 单倍型则揭示了跨越评估基因型的两组保守区域。总之,我们开发了一种基于 NGS 的 HBV 基因分型方法,利用 DB Rule 进行基因分型分类。我们在 5X 上发现了跨越不同基因型的两个保守区域,为基于 RNA 干扰的抗病毒治疗提供了有前途的靶点。